Skip to content
Open access

A Deep-Learning-Based Scoring Framework for Large-Scale Multi-donor Cardiotoxicity Screening

Aug 2026 · Computational and Structural Biotechnology Journal · Vol 35 · 0 citations · 29 references
Medicine

TL;DR

This framework establishes a scalable, human-relevant, and genetically diverse platform for cardiotoxicity surveillance across both pharmacological and environmental chemical spaces and identified microbiocides, dyes, and pesticides as chemical classes of potential concern.

Abstract

Cardiotoxicity remains a major cause of drug attrition and postmarket withdrawal, yet the vast majority of environmental chemicals to which humans may be exposed remain uncharacterized for cardiotoxicity risk. Human induced pluripotent stem cell (hiPSC)-based testing has been proposed to address this gap. Here, we present an unsupervised deep learning framework for multi-donor cardiotoxicity screening using high-throughput calcium transient recordings from hiPSC-derived cardiomyocytes (hiPSC-CMs). We analyzed data from a library of 1,029 compounds tested in hiPSC-CMs from 5 donors across a concentration range. An autoencoder trained exclusively on baseline signals quantified chemically induced functional perturbations through reconstruction error, bypassing the need for labeled training data while capturing the full spectrum of calcium-handling disruptions. Aggregation of donor-specific scores revealed substantial inter-individual variability in potential cardiotoxicity, underscoring the value of this approach for multi-donor risk prediction. We identified microbiocides, dyes, and pesticides as chemical classes of potential concern, characterized by high toxicity scores and low interdonor variability. This framework establishes a scalable, human-relevant, and genetically diverse platform for cardiotoxicity surveillance across both pharmacological and environmental chemical spaces.

Read PDF

Similar papers

Aug 2026

Transfer Learning Empowers the Development of Better-Performing Models for In Vivo Cardiotoxicity by Learning from In Vitro hERG Binding Data

Evaluating chemical hazards, such as cardiotoxicity, is critical for sound chemical management but is challenging due to the labor-intensive and time-consuming nature of in vivo testing. In silico models can efficiently and cost-effectively screen potential cardiotoxic compounds from a large number of chemicals. Howe...

Yuxuan Zhang, Yuwei Liu, Guijia Bi et al. · 0 citations
Conference Open access 2026

Drug clustering upon toxicity effects on liver spheroids – a deep learning approach

Motivation for this research stems from drug-induced liver injury (DILI) being a leading cause of drug failure and market withdrawal, which calls for reliable, non-invasive hepatotoxicity assessment. The basis for this research was the work performed by Dubinsky et al., who established a deep learning (DL) model to pre...

M. Jordovic-Pavlovic, Tijana Geroski, Milica Nikolić · 0 citations
Review Sep 2026

Shaping the Future of Predictive Toxicology with Machine and Deep Learning: A Comprehensive Review

This review discusses recent progress in ML, DL, and AI-based strategies for toxicity prediction, assesses their utility across major toxicity endpoints, and highlights the challenges and future research opportunities in predictive toxicology.

Anjali Mahavar, Atul Patel, Ashish Patel · 0 citations
Open access Sep 2026

Machine Learning for Toxicity Prediction in Low-Sample Molecular Classes

A framework that fine-tunes a general baseline model trained on publicly available data on small, class-specific datasets to retain the baseline’s generalization ability while gaining class-specific accuracy and produce probabilistic outputs that capture uncertainty in the training data is proposed.

C. Barajas, Laura L. Dunphy, Luke C. Mullany et al. · 0 citations
Open access Aug 2026

Deep Learning-Based Molecular Generation for Lung Cancer Therapeutics

Despite training on 5000 SMILES due to limited computational resources, the model achieved high validity, strong molecular diversity, and drug-like physicochemical properties, demonstrating the feasibility of a scalable, target-specific AI pipeline for lung cancer drug discovery using fragment-based molecular generatio...

Mohavia Ben Amid Sinon, U. Chude-Okonkwo · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.